![फ्यूचर्स बाजार में गिरावट, फेड के पॉवेल बोलेंगे, बोइंग याचिका सौदा - बाजार में क्या चल रहा है](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEIAC09E_L.jpg)
कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
CYBN | CBOE कनाडा | CAD | रियल टाइम | |
CYBN | NYSE | USD | रियल टाइम | |
R7E1 | ट्रेडगेट | EUR | देरी |
Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. The company’s development pipeline includes CYB003, a deuterated psilocybin analog, which is in phase 1/2a clinical trial to treat major depressive disorder (MDD) and alcohol use disorder; CYB004, a deuterated dimethyltryptamine (DMT), which completed phase 2 clinical trial for treating generalized anxiety disorders; SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 completed phase 1, 1b, and 1/2a for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat neuroinflammation; as well as has a research pipeline of investigational psychedelic-based compounds. It has also developed EMBARK, a psychological support model that integrates clinical approaches to promote supportive healing with psychedelic medicine. The company has research and collaboration agreement with TMS Neurohealth Centers Inc. for development of psychedelic compound-based therapeutics; Kernel for use of Kernel flow technology to measure neural activity; and Greenbook TMS to establish mental health centers. The company is headquartered in Toronto, Canada.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Anthony Back | - | 2021 | Member of Clinical Advisory Board |
Thomas P. Laughren | - | 2021 | Member of Clinical Advisory Board |
Lynn Marie Morski | - | 2021 | Member of Clinical Advisory Board |
Maurizio Fava | - | 2021 | Member of Clinical Advisory Board |
Paul Glavine | 33 | 2020 | Co-Founder, Chief Growth Officer & Director |
Eric So | 46 | 2020 | Co-Founder, President & Executive Chairman |
Eric William Hoskins | 62 | 2020 | Independent Director |
Grant B. Froese | 61 | 2020 | Independent Director |
Theresa S. Firestone | 68 | 2021 | Lead Independent Director |
George Tziras | - | 2023 | Chief Business Officer & Director |
Mark A. Lawson | 51 | 2020 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है